Agoraphobia: a review of the diagnostic classificatory position and criteria.

Institute of Clinical Psychology and Psychotherapy, Technische Universitaet Dresden, D-01187Dresden, Germany.
Depression and Anxiety (Impact Factor: 4.29). 02/2010; 27(2):113-33. DOI: 10.1002/da.20646
Source: PubMed

ABSTRACT The status of agoraphobia (AG) as an independent diagnostic category is reviewed and preliminary options and recommendations for the fifth edition of The Diagnostic and Statistical Manual (DSM-V) are presented. The review concentrates on epidemiology, psychopathology, neurobiology, vulnerability and risk factors, clinical course and outcome, and correlates and consequences of AG since 1990. Differences and similarities across conventions and criteria of DSM and ICD-10 are considered. Three core questions are addressed. First, what is the evidence for AG as a diagnosis independent of panic disorder? Second, should AG be conceptualized as a subordinate form of panic disorder (PD) as currently stipulated in DSM-IV-TR? Third, is there evidence for modifying or changing the current diagnostic criteria? We come to the conclusion that AG should be conceptualized as an independent disorder with more specific criteria rather than a subordinate, residual form of PD as currently stipulated in DSM-IV-TR. Among other issues, this conclusion was based on psychometric evaluations of the construct, epidemiological investigations which show that AG can exist independently of panic disorder, and the impact of agoraphobic avoidance upon clinical course and outcome. However, evidence from basic and clinic validation studies remains incomplete and partly contradictory. The apparent advantages of a more straightforward, simpler classification without implicit hierarchies and insufficiently supported differential diagnostic considerations, plus the option for improved further research, led to favoring the separate diagnostic criteria for AG as a diagnosis independent of panic disorder.


Available from: Andrew T Gloster, Sep 26, 2014
1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Agoraphobia is a burden by persistent excessive activation of the acute stress response system, but to date, little is known about chronic low-grade systemic inflammation and agoraphobia. We aimed to assess whether individuals with lifetime agoraphobia are at a higher risk to exhibit chronic low-grade inflammation over time and to identify predictors being associated with pro-inflammatory activity in agoraphobia, including cardiovascular risk factors. Methods: In a random Swiss population sample of 2890 persons (35-67 years, 53% women)In this epidemiological study, we systematically measured levels of circulating pro-inflammatory markers at baseline and at a mean follow-up of 66 ± 4.8 months (range 30 - 102) and assessed potential confounding covariates in a random Swiss population sample of 2890 persons (35-67 years, 53% women). Among them, a total of 124 individuals (4.3%) were diagnosed with lifetime agoraphobia using the semi-structured Diagnostic Interview for Genetic Studies. Multivariate linear regression models considered socio-demographic factors, clinical variables, health behaviors, and other major psychiatric diseases. Results: After adjustment for various covariates Individuals individuals with agoraphobia had significantly higher follow-up levels of C-reactive protein (p = 0.010) and tumor-necrosis-factor (p = 0.047) as well as lower levels of the cardioprotective marker adiponectin (p = 0.032) than their non-agoraphobic counterparts. Follow-up levels of interleukin (IL)-1 and IL-6 did not significantly differ between the two groups. The severity of agoraphobia had no further impact on the circulating levels of pro-inflammatory markers. Conclusions: An accompanying increase in glucocorticoids and glucocorticoid receptor desensitization through chronic glucocorticoid stimulation might be a mechanism that explaining explains the chronic low-grade inflammation in agoraphobics over time, which needs to be tested in mechanistic studies.
    PLoS ONE 04/2015; 10(4). DOI:10.1371/journal.pone.0123757 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Age of onset is an important epidemiological indicator in characterizing disorders' subtypes according to demographic, clinical and psychosocial determinants. While investigated in various psychiatric conditions, age of onset and related characteristics in agoraphobia have yet to be examined. In light of the new diagnostic status in the DSM-5 edition of agoraphobia as independent from panic disorder, research on agoraphobia as a stand-alone disorder is needed.
    Journal of Affective Disorders 04/2015; 180. DOI:10.1016/j.jad.2015.03.064 · 3.71 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: 15–59 ปี จำ านวน 17,140 คน สุ ่ มแบบ stratified three-stage cluster sampling ด้ วยเครื ่ องมื อวิ นิ จฉั ยโรค Mini International Neuropsychiatric Interview (M.I.N.I.) ฉบั บภาษาไทย สั มภาษณ์ โดยบุ คลากรสุ ขภาพจิ ต คิ ดค่ าสถิ ติ จาก ค่ าประมาณสั ดส่ วนโดยการถ่ วงน้ ำ าหนั ก ผล พบความชุ กของโรคจิ ตเวชร่ วมร้ อยละ 1.4 โดยพบโรคจิ ตเวชร่ วมภายในกลุ ่ มโรคเดี ยวกั น (homotypic comorbidity) ร้ อยละ 0.3 และโรคจิ ตเวชร่ วมระหว่ างกลุ ่ มโรคต่ างกั น (heterotypic comorbidity) ร้ อยละ 1.1 โรคจิ ตเวชร่ วมภายในกลุ ่ มโรคเดี ยวกั นพบ mixed bipolar disorder ร้ อยละ 34.7 ของ bipolar disorder ทั